Lay Health Worker Led Symptom Assessment Intervention
Joint Oncology Collaboration for Proactive Symptom Assessments by a Lay Health Worker
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Clinical diagnosis of stage 3 and 4 cancer
- Clinical diagnosis of hematologic malignancy
- Must receive care at the Oncology Institute of Hope and Innovation
- Must be an enrollee of CareMore Medicare Advantage
Exclusion Criteria:
None
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Edmonton Symptom Assessment Scale Score (ESAS)
Time Frame: 12 months after patient enrollment
|
ESAS measures participant responses to 10 common symptoms (pain, fatigue, nausea, depression, anxiety, drowsiness, shortness of breath, appetite, sleep problems, and feeling of well-being).
Participants rate the intensity of 10 symptoms, each on a 11-point scale (0 to 10); sub-scores are then summed and averaged to create a total symptom score (range: 0 to 10, with 10 corresponding to worst symptom severity).
|
12 months after patient enrollment
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Total Health Care Costs (Claims Review)
Time Frame: 12 months after patient enrollment
|
Total Health Care Costs for each patient will be abstracted by medical claims data review for each patient at 12 months after enrollment.
|
12 months after patient enrollment
|
|
Hospitalization Visits (Claims Review)
Time Frame: 12 months after patient enrollment
|
Hospitalization Use for each patient will be abstracted by medical claims data review for each patient at 12 months after enrollment.
|
12 months after patient enrollment
|
|
Intensive Care Unit Visits (Claims Review)
Time Frame: 12 months after patient enrollment
|
Intensive Care Unit Visits for each patient will be abstracted by medical claims data review for each patient at 12 months after enrollment.
|
12 months after patient enrollment
|
|
Incidence of Emergency Department Visits
Time Frame: 12 months after patient enrollment
|
Emergency Department use for each patient abstracted from medical claims data review for each patient at 12 months after enrollment.
|
12 months after patient enrollment
|
|
Change in Patient Satisfaction With Care Using the Consumer Assessment of Health Care Providers and Systems -General Survey
Time Frame: Change in Patient Satisfaction with Care from baseline to 5 months.
|
Each patient will receive a satisfaction with care survey (The Consumer Assessment of Health Care Providers and Systems - General (CAHPS)) at baseline and 5 months.
We will measure the change in satisfaction from calculated as the value at 5 months minus the baseline value.
Scores for satisfaction were assessed using the Consumer Assessment of Healthcare Providers and Systems-General survey question #18 which measured rating of health provider, on which scores range from 0 to 10, with higher ratings correspond to higher patient satisfaction.
Scores for each group are averaged at baseline and at 12 months.
|
Change in Patient Satisfaction with Care from baseline to 5 months.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- SU12
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.